We are Imperial College Healthcare
Imperial College Healthcare NHS Trust provides acute and specialist healthcare for over one million people every year. We particularly serve the local communities in the eight boroughs that form the North West London Integrated Care System. Formed in 2007, we are one of the largest NHS trusts in the country, with more than 15,000 staff.
Our five hospitals in central and west London – Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s and The Western Eye – have a long track record in research and education, influencing care and treatment nationally and worldwide. We are developing a growing range of integrated and digital care services and offer private healthcare in dedicated facilities on all our sites, including at the Lindo Wing at St Mary’s Hospital.
Find out more about how we're runBuilding better hospitals
All three of the Trust’s main sites are included in the Government’s New Hospital Programme. This includes a full rebuild of St Mary’s and major refurbishment and some new build at both Charing Cross and Hammersmith hospitals. A new Western Eye Hospital is expected to be incorporated into whichever is the most suitable of the developments.
Latest news See all news
-
Read the full story
Volunteer Employability Programme is changing lives, and applications are open
Unemployment and poverty are among the biggest factors that may impact an individual’s health – and we know there are significant health inequalities affecting the patient population in north west London. To help address this challenge, Imperial…
-
Read the full story
Innovative medical implant found to relieve chest pain
An innovative medical device, known as a coronary sinus reducer, has been found to relieve chest pain from reduced blood flow to the heart.
-
Read the full story
Kidney transplant patients to get blood matched for white blood cells in new pilot
When needed, kidney transplant patients at Hammersmith Hospital will get blood transfusions matched not just for red blood cells but also for the donor’s tissue type, as part of a new pilot programme.